SEC Form 4 · accession 0001193805-15-000421
ADMA BIOLOGICS, INC. · ADMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Lenz
Officer — Chief Financial Officer
Period of report
Mar 19, 2015
Accepted (ET)
Mar 23, 2015 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001368514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per share | Mar 19, 2015 | P | 200 | $8.82 | A | 4,450 | D | |
| Common Stock, $0.0001 par value per share | Mar 19, 2015 | P | 550 | $9.00 | A | 5,000 | D |
Table II — derivative securities
No Table II lines on this filing.